Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Certolizumab pegol in active Crohn's disease (MUSIC)
NCT00297648Phase 3Completed
- Sponsor
- UCB
- Start
- Feb 2006
- Primary completion
- Jan 2008
- Modality
- Antibody Fragments, Polymer-based Nanoparticles
- Countries
- 3
01
Overview
A Phase 3 trial of certolizumab pegol in Crohn's disease, sponsored by UCB. Started Feb 2006; status: completed.
02
Drugs
certolizumab pegol
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00297648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00297648.